ImmunoPrecise Antibodies Ltd.
IPA
Price:
$1.62
Market Cap:
$79.44M
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, V...[Read more]
Industry
Biotechnology
IPO Date
2002-01-07
Stock Exchange
NASDAQ
Ticker
IPA
PE Ratio
[-2.45]
ROE
[-140.47%]
Current Ratio
[4.19]
Dividend Yield
[0%]
Enterprise Value
[66.55M]
Dividend History
The ROE as of March 2026 (TTM) for ImmunoPrecise Antibodies Ltd. (IPA) is -140.47%
According to ImmunoPrecise Antibodies Ltd.’s latest financial reports and current stock price. The company's current ROE is -140.47%. This represents a change of 331.26% compared to the average of -32.57% of the last 4 quarters.
ImmunoPrecise Antibodies Ltd. (IPA) Historical ROE (quarterly & annually)
How has IPA ROE performed in the past?
The mean historical ROE of ImmunoPrecise Antibodies Ltd. over the last ten years is -58.97%. The current -140.47% ROE has changed 138.23% with respect to the historical average. Over the past ten years (40 quarters), IPA's ROE was at its highest in in the December 2015 quarter at 1.81%. The ROE was at its lowest in in the September 2016 quarter at -331.05%.
Average
-58.97%
Median
-41.97%
Minimum
-180.14%
Maximum
-3.80%
ImmunoPrecise Antibodies Ltd. (IPA) ROE by Quarter and Year
Discovering the peaks and valleys of ImmunoPrecise Antibodies Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.64%
Maximum Annual ROE = -3.80%
Minimum Annual Increase = -112.68%
Minimum Annual ROE = -180.14%
| Year | ROE | Change |
|---|---|---|
| 2025 | -126.87% | 62.84% |
| 2024 | -77.91% | 65.49% |
| 2023 | -47.08% | 107.42% |
| 2022 | -22.70% | 76.03% |
| 2021 | -12.89% | -62.45% |
| 2020 | -34.34% | -20.17% |
| 2019 | -43.02% | 5.14% |
| 2018 | -40.91% | -77.29% |
| 2017 | -180.14% | 4.64% |
| 2016 | -3.80% | -112.68% |
ImmunoPrecise Antibodies Ltd. (IPA) Average ROE
How has IPA ROE performed in the past?
The current ROE of ImmunoPrecise Antibodies Ltd. (IPA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-83.95%
5-year avg
-57.49%
10-year avg
-58.97%
ImmunoPrecise Antibodies Ltd. (IPA) ROE vs. Peers
How is IPA’s ROE compared to its peers?
ImmunoPrecise Antibodies Ltd.’s ROE is greater than IGM Biosciences, Inc. (-93.35%), greater than Jade Biosciences, Inc. (-64.64%), greater than Quince Therapeutics, Inc. (-370.46%), greater than Landos Biopharma, Inc. (-61.86%), greater than Surface Oncology, Inc. (-61.52%), greater than Heat Biologics, Inc. (-17391.43%), greater than Berkeley Lights, Inc. (-55.98%), less than Reneo Pharmaceuticals, Inc. (0%), greater than Achilles Therapeutics plc (-41.05%), greater than Miromatrix Medical Inc. (-74.80%),
| Company | ROE | Market cap |
|---|---|---|
| -93.35% | $77.50M | |
| -64.64% | $454.15M | |
| -370.46% | $5.93M | |
| -61.86% | $71.68M | |
| -61.52% | $65.08M | |
| -17391.43% | $61.07M | |
| -55.98% | $86.61M | |
| 0% | $60.84M | |
| -41.05% | $60.83M | |
| -74.80% | $92.95M |
Build a custom stock screener for ImmunoPrecise Antibodies Ltd. (IPA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmunoPrecise Antibodies Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
ImmunoPrecise Antibodies Ltd. (IPA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like ImmunoPrecise Antibodies Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is ImmunoPrecise Antibodies Ltd.'s ROE?
How is the ROE calculated for ImmunoPrecise Antibodies Ltd. (IPA)?
What is the highest ROE for ImmunoPrecise Antibodies Ltd. (IPA)?
What is the 3-year average ROE for ImmunoPrecise Antibodies Ltd. (IPA)?
What is the 5-year average ROE for ImmunoPrecise Antibodies Ltd. (IPA)?
How does the current ROE for ImmunoPrecise Antibodies Ltd. (IPA) compare to its historical average?